Ouzir

Ouzir

Under the high Patronage of His Majesty King Mohammed VI, the Mohammed V University of Rabat organizes the 9th Pan African Congress of Mathematicians 2017 (PACOM 2017) from 3 to 7 July 2017 at the Faculty of Sciences under the theme: “Mathematics at the heart of technological innovation and economic development of Africa ".

The program includes three satellite conferences: EduMaths to be held at the Ecole Normale Supérieure (ENS) in Rabat on 4th of July, MathLogy organized on 5th of July at the Hassan II Academy of Sciences and Techniques and W-PACOM 2017 organized by the International University of Rabat on 5th and 6th of July. This congress welcomes 500 participants; among them prestigious medals & Prizes awardees like: Professors Yves Meyer (Carl Friedrich Gauss 2010 Prize and Abel 2017 Prize), Vaughan F.R. Jones (Fields Medal 1990), Martin Hairer (Fields Medal 2014), Jill Adler (Hans Freudenthal 2015 Prize), etc….

On the framework of this congress and in accordance with the tradition of previous PACOM editions, the African Mathematical Union (AMU) organizes the 25th Pan-African Mathematics Olympiad at the ENS from 1 to 6 July 2017.

For more information visit the PACOM 2017 website

 

PROGRAM

03 July 2017

Opening Ceremony (Cocktail, Opening Conference, Plenary Conference, Afrikan Queens Exposition, Choral FSR) at Mohammed V- Rabat Theater (08:00-13:00)

03- 07 July 2017

PACOM 2017 - Faculty of Sciences Rabat (17 Plenary Conferences, 45 invited lecture (45mn) and 45 Oral Communications (20mn) in Parallels Sessions, Posters, Round Tables, UNESCO Workshop, Exhibition stands etc….

04 July 2017

EduMaths - Ecole Normale Supérieure of Rabat

Symposium Mathematical Modelling of Complexity in Life Sciences - Ibn Tofail University

05 July 2017

MathLogy - Hassan II Academy of Sciences and Technics Rabat

Round Table UNESCO - Hassan II Academy of Sciences and Technics Rabat

05 - 06 July 2017

W-PACOM 2017 - International University of Rabat 

01 - 06 July 2017

25th Pan-African Mathematics Olympiad - Ecole Normale Supérieure of Rabat

HONORARY COMMITTEE

  • Mohamed Hassad, Minister of National Education, Vocational Training, Higher Education and Scientific Research Morocco
  • Mary Teuw Niane, Minister of High Education and Scientific Research of Senegal
  • Irina Bokova, Director-General of UNESCO, France
  • Abdellatif Jouahri Governor of Bank-Al–Magrib, Morooco
  • Janvier Liste, Director-General (West Africa) of the African Development Bank (ADB) Côte d’Ivoire
  • Saaid Amzazi, President of Mohammed V University in Rabat, Morocco
  • Adewale Solarin, President of African Mathematical Union (AMU), Nigeria
  • Mostafa Terrab, President General Director of Office Chérifien des Phosphates, Morocco
  • Abdeslam Ahizoun, President General Director of Itissalat Al Maghrib (IAM) Morocco
  • Miriem Bensalah-Chaqroun, Presidente General Director of General Confederation of Moroccan Companies, Morocco
  • Azzeddine El Midaoui, President of Ibn Tofail University, Morocco
  • Mourad El Belkacemi Dean of Faculty of Sciences Rabat, Morocco
  • Nordine Mouaddab, International University of Rabat, Morocco
  • Omar Fassi-Fihri, Permanent Secretary of the Hassan II Academy of Sciences and technics, Morocco
  • Abdeljalil Lahjomri, Permanent Secretary of the Kingdom of Morocco’s Academy, Morocco

INTERNATIONAL PACOM COMMITTEE

Chair: Adewale Solarin, AMU President

Co-Chair: Nouzha El Yacoubi, AMU Vice-President (North Africa)

  • Aderemi Kuku, AMU Honorary President 
  • Saliou Touré, AMU Honorary President 
  • Oluwole Daniel Makinde, AMU Secretary General  
  • Guy Nket, AMU Vice -President (Central Africa)
  • Wandera Ogana, AMU Vice-President (East Africa)
  • Winter Sinkala, AMU Vice-President (Southern Africa)
  • Adama Coulibaly, AMU Vice-President (West Africa)  
  • Mohamed El Tom, AMU Council member 
  • Joel Moitsheki, AMU Council member 
  • Raouf Thabet, AMU Council member 
  • Leonard Todjhounde, AMU Council member 

ORGANIZING COMMITTEE

   

Nouzha El Yacoubi

Rachida Hassikou

Noha El Khattabi

Jilali Mikram

Nadir Maaroufi

Manale El Hamri

Soukaina Sabir

Mounir Ouzir

Loubna Terhzaz

Ismail El Moudden

Nabil Moukafih

Mourad El Belkacemi

Nadia Raissi

El Hassan Zerouali

Souad El Bernoussi

My Mohammed Ouahidi

Hamza El Azhar

Hatim Naqos

Hafid Bahajji- El Idrissi

Samir Belfkih

Kaoutar Taha

Ibtihaj El Mamoun


Peer review is the system for evaluating the quality, validity, and relevance of scholarly research. The process aims to provide authors with constructive feedback from relevant experts which they can use to make improvements to their work, thus ensuring it is of the highest standard possible. Authors expect reviews to contain an honest and constructive appraisal, which is completed in a timely manner and provides feedback that is both clear and concise.

What is peer review?

Peer review, also known as refereeing, is a collaborative process that allows manuscripts submitted to a journal to be evaluated and commented upon by independent experts within the same field of research. The evaluation and critique generated from peer review provides authors with feedback to improve their work and, critically, allows the editor to assess the paper’s suitability for publication in the journal. The peer-review process does receive much criticism and is not without its limitations; however, it remains a widely recognized standard in terms of journal quality.

Why review?

  • To help authors improve their papers, applying your professional expertise to help others.
  • To assist in maintaining a good, rigorous peer-review process resulting in the publication of the best and brightest – you can have a part in championing the next key paper in your own field of interest.
  • To maintain awareness of the current research emerging within your subject area.
  • To build relationships with the editorial team of a journal and improve your academic and professional profile.
  • Although often anonymous, the review process can act as a conversation between author, reviewer, and editor as to how the paper can be improved to maximize its impact and further research in the field.
  • Help to draw attention to any gaps in references and make the author aware of any additional literature that may provide useful comparison, or clarification of an approach.
  • To gain a sense of prestige in being consulted as an expert.

What to consider before saying 'yes' to reviewing

Before agreeing to review for a journal, you should take note of the following:

  • What form of review does the journal operate? (single/blind/open)
  • How you will need to submit your review – for example, is there a structured form for reviewers to complete or will you be required to write free text?
  • Papers and correspondence sent to reviewers in the course of conducting peer review are to be dealt with as privileged confidential documents.
  • If a conflict of interest exists, you should make the editor aware of this as soon as possible.
  • Whether you are able to complete the level of review required by the editor in the allotted time – extensions can be provided or a brief report may suffice on some occasions. If you are struggling to meet the deadline, let the editor know, so they can inform the author if there is a delay.

Writing a review: a step-by-step guide

Research:

1. Investigate the journal’s content

  • Visit the journal homepage (on Taylor & Francis Online) to get a sense of the journal’s published content and house style. This will help you in deciding whether the paper being reviewed is suitable or not.
  • Refer to the Instructions for Authors to see if the paper meets the submission criteria of the journal (e.g. length, scope, and presentation).
  • Complete the review questions or report form to indicate the relative strengths or weaknesses of the paper.
  • A referee may disagree with the author’s opinions, but should allow them to stand, provided they are consistent with the available evidence.
  • Remember that authors will welcome positive feedback as well as constructive criticism from you.

Writing your report:

2. Make an assessment

  • Complete the review questions or report form to indicate the relative strengths or weaknesses of the paper.
  • A referee may disagree with the author’s opinions, but should allow them to stand, provided they are consistent with the available evidence.
  • Remember that authors will welcome positive feedback as well as constructive criticism from you.

3. Answer key questions

The main factors you should provide advice on as a reviewer are the originality, presentation, relevance, and significance of the manuscript’s subject matter to the readership of the journal.

Try to have the following questions in mind while you are reading the manuscript:

  • Is the submission original?
  • Is the research cutting edge or topical?
  • Does it help to expand or further research in this subject area?
  • Does it significantly build on (the author’s) previous work?
  • Does the paper fit the scope of the journal?
  • Would you recommend that the author reconsider the paper for a related or alternative journal?
  • Should it be shortened and reconsidered in another form?
  • Would the paper be of interest to the readership of the journal?
  • Is there an abstract or brief summary of the work undertaken as well as a concluding section? Is the paper complete?
  • Is the submission in Standard English to aid the understanding of the reader? For non-native speakers, an English editing service may be useful (see our Author Services website for advice).
  • Is the methodology presented in the manuscript and any analysis provided both accurate and properly conducted?
  • Do you feel that the significance and potential impact of a paper is high or low?
  • Are all relevant accompanying data, citations, or references given by the author?

Other aspects to consider

Abstract – Has this been provided (if required)? Does it adequately summarize the key findings/approach of the paper?

Length – Reviewers are asked to consider whether the content of a paper is of sufficient interest to justify its length. Each paper should be of the shortest length required to contain all useful and relevant information, and no longer.

Originality – Is the work relevant and novel? Does it contain significant additional material to that already published?

Presentation – Is the writing style clear and appropriate to the readership? Are any tables or graphics clear to read and labeled appropriately?

References – Does the paper contain the appropriate referencing to provide adequate context for the present work?

4. Make a recommendation

Once you’ve read the paper and have assessed its quality, you need to make a recommendation to the editor regarding publication. The specific decision types used by a journal may vary but the key decisions are:

  • Accept – if the paper is suitable for publication in its current form.
  • Minor revision – if the paper will be ready for publication after light revisions. Please list the revisions you would recommend the author makes.
  • Major revision – if the paper would benefit from substantial changes such as expanded data analysis, widening of the literature review, or rewriting sections of the text.
  • Reject – if the paper is not suitable for publication with this journal or if the revisions that would need to be undertaken are too fundamental for the submission to continue being considered in its current form.

5. Provide detailed comments

  • These should be suitable for transmission to the authors: use the comment to the author as an opportunity to seek clarification on any unclear points and for further elaboration.
  • If you have time, make suggestions as to how the author can improve clarity, succinctness, and the overall quality of presentation.
  • Confirm whether you feel the subject of the paper is sufficiently interesting to justify its length; if you recommend shortening, it is useful to the author(s) if you can indicate specific areas where you think that shortening is required.
  • It is not the job of the reviewer to edit the paper for English, but it is helpful if you correct the English where the technical meaning is unclear.

Think about the following when compiling your feedback:

  • Does the paper make a significant contribution to contemporary [subject]?
  • Is the research likely to have an impact on [subject] practice or debate?
  • Does the paper present or expand upon novel or interesting ideas?
  • Is the paper likely to be of sufficient interest to be cited by other researchers?
  • Are the methods, analysis, and conclusions robust and to a high standard?
  • Is the paper well integrated and up to date with the existing body of literature?
  • Being critical whilst remaining sensitive to the author isn’t always easy and comments should be carefully constructed so that the author fully understands what actions they need to take to improve their paper. For example, generalized or vague statements should be avoided along with any negative comments which aren’t relevant or constructive.

See the “sample comments” section for examples on how to phrase your feedback.

Revised papers

When authors make revisions to their article in response to reviewer comments, they are asked to submit a list of changes and any comments for transmission to the reviewers. The revised version is usually returned to the original reviewer if possible, who is then asked to affirm whether the revisions have been carried out satisfactorily.

What if you are unable to review?

Sometimes you will be asked to review a paper when you do not have sufficient time available. In this situation, you should make the editorial office aware that you are unavailable as soon as possible. It is very helpful if you are able to recommend an alternative expert or someone whose opinion you trust.

If you are unable to complete your report on a paper in the agreed time-frame required by the journal, please inform the editorial office as soon as possible so that the refereeing procedure is not delayed.

Make the editors aware of any potential conflicts of interest that may affect the paper under review.

Sample comments

Please note that these are just examples of how you might provide feedback on an author’s work. Your review should, of course, always be tailored to the paper in question and the specific requirements of the journal and the editor.

Positive comments

  • The manuscript is well-written in an engaging and lively style.
  • The level is appropriate to our readership.
  • The subject is very important. It is currently something of a “hot topic,” and it is one to which the author(s) have made significant contributions.
  • This manuscript ticks all the boxes we normally have in mind for an X paper, and I have no hesitation in recommending that it be accepted for publication after a few typos and other minor details have been attended to.
  • Given the complexity involved, the author has produced a number of positive and welcome outcomes including the literature review which offers a useful overview of current research and policy and the resulting bibliography which provides a very useful resource for current practitioners.
  • This is a well-written article that does identify an important gap.

When constructive criticism is required

  • In the “Discussion” section I would have wished to see more information on…
  • Overall I do not think that this article contains enough robust data to evidence the statement made on page X, lines Y–Z.
  • I would strongly advise the author(s) of this paper to rewrite their introduction, analysis, and discussion to produce a more contextualized introduction to…
  • There is an interesting finding in this research about .... However, there is insufficient discussion of exactly what this finding means and what its implications are.
  • This discussion could be enlarged to explain…
  • The authors could strengthen the paper by…
  • The paper would be significantly improved with the addition of more details about…
  • The abstract is very lengthy and goes into detailed accounts that are best suited for the article’s main discussion sections. As such, it is suggested the section is reduced in size and that only the most important elements remain.
  • To make this paper publishable the author needs to respond to the following substantive points...

When linguistic alterations are required

  • This paper would benefit from some closer proof reading. It includes numerous linguistic errors (e.g. agreement of verbs) that at times make it difficult to follow. I would suggest that it may be useful to engage a professional English language editor following a restructure of the paper.
  • The paper is to benefit from making stylistic changes in the way it has been written to make a stronger, clearer, and more compelling argumentative case.
  • There are a few sentences that require rephrasing for clarity.

Additional reviewer resources:

Peer review section of our Author Services website: http://journalauthors.tandf.co.uk/review/peer.asp

ScholarOne Manuscripts user guidelines: http://mchelp.manuscriptcentral.com/gethelpnow/guides.htm

ScholarOne Manuscripts Optima integrates elements of ScholarOne Manuscripts with Web of ScienceTM and EndNote from Thomson Reuters to give a range of tools that help make the lives of reviewers easier when using the system: http://editorresources.taylorandfrancisgroup.com/scholarone-manuscripts-optima/

Source


Abeslam El Khamlichi was born 16 March 1948 in Beni Amart north of Morocco. Professor El Khamlichi is one of the neurosurgery pioneers in Morocco. He started his specialty since1970s. Appointed as head of department at Hospital of Specialties in 1983 and Professor at Medical School of Rabat in 1984 respectively, Prof El Khamlichi will show during all his career that his passion for neurosurgery is only equaled by the his devotion for developing neurosurgery in the public sector which will lead him to create in 1989 the II Hassan Foundation of Prevention and Cure of Diseases System Nervous. He became Director of the WFNS Rabat Reference Center for Training of African Neurosurgeons since2002 and Director of the National Center of Neurosciences and Rehabilitation in Rabat since 2008. Professor El Khamlichi has been invited as Visiting Professor by more than 30 universities from over 5 continents.  He organized the 13th World Congress of Neurological Surgery in Marrakech, June 2005 and has trained generations of Moroccan and African neurosurgeons. He is also a founding member and Past President of the Pan Arab Neurosurgical Society, founding member and Past President of the Maghrebian Federation of Neurosurgical Societies and was the Chairman of the WHO African Working Group in Neurosurgery, 1996. He is an active member of the WFNS (World Federation of Neurosurgical Societies), SNCLF (French-Speaking Society of Neurosurgery), AANS (American Association of Neurological Surgeons), CNS (Congress of Neurological Surgeons), founding member of the WANS (World Academy of Neurological Surgeons) and associate member of the Japanese Society of Neurological Surgeons, member of the WHO Working Group in Neurosurgery. Research publications include 5 books and 105 articles, 82 among them published in international journals.

Awards and Prizes: He received 6 medals, 13 certificates of merit and 3 awards at national, regional and international levels. He became Honorary President of the World Federation of Neurosurgical Societies in September 2011.

Abdelhamid Benazzouz is a Neurophysiologist Researcher employed by the Inserm Institute working in Bordeaux University. He is expert in the field of Neuroscience and especially in Parkinson’s disease. After completing a Master degree in Morocco, he went to Bordeaux to prepare his PhD diploma in the field of Neuroscience and Pharmacology that he obtained in 1993. Dr. Benazzouz was the first to develop high frequency stimulation (HFS), named also deep brain stimulation (DBS), of the subthalamic nucleus (STN) as a therapeutical approach of Parkinson’s disease. The results obtained were spectacular; rigidity disappeared and akinesia was hardly observable. Impressed by these results, he proposed the transfer of this neurosurgical approach to parkinsonian patients. He joined as a Neurophysiologist Research Fellow the Inserm unit of Professor Alim-Louis Benabid in Grenoble to participate in transfering this approach to parkinsonian patients, with a success that has never failed since. In parallel with his hospital activity as a Neurophysiologist performing the electrophysiological mapping during surgery, he was the head of a research team in the Inserm unit investigating the functional mechanisms of this approach in animal models. In 1998 he was appointed to Inserm position as a permanent position researcher. In 2001, he came back to Bordeaux as a Principal Investigator in the CNRS unit of Professor Bernard Bioulac. In 2005 he was promoted to Research Director position. Since 2011, he is the leader of the Team "Neurochemistry, Deep Brain Stimulation & Parkinson’s disease" in the Institute of Neurodegenerative diseases in Bordeaux University, in which he is investigating the respective role of monoamines in the pathophysiology of motor and non-motor symptoms of Parkinson’s disease. He has published more than 104 research papers in peer-reviewed journals and 25 chapters in scientific books as well as more than 70 research contributions at international conferences, international Neuroscience Schools and Universities. Internationally ranked among distinguished scholars, his publications are cited more than 15 thousand times and received 53 degrees on the global H-Index (Google Scholar).

Awards and Prizes: He obtained the National Academy of Medicine award in 2003 and the Academy of Science award in 2007. In 2010, He obtained the distinction of Scientific Excellence delivered by INSERM.

Abdeljabbar El Manira is a native of Rabat where he grew up and studied most of his life. Dr. El Manira received his BSc from the Faculté des Science, Rabat, Morocco and Ph.D. from the University of Marseille, France. He joined the Karolinska as a postdoctoral fellow to work on the spinal locomotor networks in the lamprey. He also spent 3 months at the Marine Biological Laboratory in Woods Hole as a Grass fellow. Dr. El Manira is currently a Professor at the Department of Neuroscience, Karolinska Institute where he is studying the organization and plasticity of the spinal networks controlling locomotion. His laboratory is using both the lamprey and zebrafish as model systems in which a range of molecular, imaging and electrophysiological techniques are used to study the locomotor circuitry. Research publications include more than 80 articles.

Awards and Prizes: King Mohammed VI decorated him in 2010 when he became a distinguished professor at Karolinska Institutet. In 2015, professor El Manira was elected member of the prestigious Royal Swedish Academy of Sciences that awards the Nobel Prizes.

Mimoun Azzouz was born in 1967 and graduated in Biology and Neuroscience from the University of Rabat in 1993. He obtained a Master in Neuroscience with 1st Class Honours from the University of Marseille in 1994. In 1997 he was awarded a PhD in Neuropharmacology at the University Louis Pasteur in Strasbourg. He then worked as postdoctoral scientist at the Gene Therapy Center in Lausanne, Switzerland from 1997 to 2000. He was recruited in 2000 by Oxford BioMedica plc as Senior Scientist then appointed as Director of Neurobiology in 2003. He was also a visiting scientist at Oxford University between 2000 and 2005. In 2006, he was invited to join the University of Sheffield and was appointed to the Chair of Translational Neuroscience. Professor Azzouz is currently Deputy Head of Neurology Unit and Director of Research & Innovation. He has several managerial tasks within the department and at the Faculty level. His track record of translational research productivity is characterized by publications in top ranking scientific journals, including Nature, Nature Medicine, Nature Neuroscience, Science Translational Medicine and JCI. One of his major achievements is his involvement in a gene therapy approach designed to achieve dopamine replacement in models of Parkinson’s disease. This strategy has yielded significant translational impact having entered into phase I/II human clinical trials since 2008. His pioneering work, which has already produced major breakthroughs in animal models, has short and medium term potential for real translation into major therapeutic advances for human neurodegenerative disease. He has been successful in attracting an array of scientific awards and funding from prestigious funding bodies.  He is frequently invited as a plenary lecturer at international scientific and clinical meetings where his work generates intense interest from the scientific community. He is/has been advisor for pharmaceutical companies and academic institutions. He is currently a member of the editorial board of various journals and member of scientific Panels/Boards for various funding bodies such as the Medical Research Council (Translational MRC Panel, UK), the French Muscular Dystrophy Association (AFM), The Research Council of Norway, the Health Research Board (HRB) of Ireland and the Neuroscience Board, Germany. He has been elected as Board member of the British Society of Gene and Cell Therapy Society in 2016.

Awards and Prizes: He recently won the prestigious ERC Advanced Investigator Award (2011). This award is a top level EU ad hominem award acknowledging his pre-eminence in European biomedical research. He has been nominated for the prestigious Shaw Price. He has been a key academic partner in the successful fundraising of £18M necessary to build the new Sheffield Institute for Translational Neuroscience (SITraN).

Mohamed Kabbaj was born in 1967 and graduated in Animal physiology in 1991. He obtained a Master in Neuroscience from the University of Bordeaux II Bordeaux, France in 1993.  In 1997 he was awarded a PhD in Behavioral Neuroscience at the University Bordeaux II.  He then worked as postdoctoral scientist at the University of Michigan, from 1997 to 2001. He was recruited in 2001 as Research Investigator at University of Michigan and a FSU Fulbright Student Selection Committee.  Dr. Kabbaj joined the department of biomedical sciences at the College of Medicine as an Assistant Professor of Biomedical Sciences from 2002 to 2008.   Dr. Kabbaj is a Professor conducting research in the area of stress and drug addiction. Dr. Kabbaj teaches a course in Neuropharmacology within the neuroscience program, facilitates small-group sessions with medical students and teach in various courses within the BMS PHD program.  Dr. Kabbaj uses animal models (rats, mice and voles) to examine the neurobiology of sex and individual differences in stress and drug addiction. He is also examining epigenetic mechanisms underlying social behaviors.

Awards and Prizes: He received the outstanding faculty investigator award in 2014, the Faculty Council Award Outstanding Senior Faculty Researcher in 2009 and the Developing Scholar Award, Florida State University in 2011. In 2016, Dr. Kabbaj has received a $1.9 million grant from the National Institute of Mental Health to study how the brain helps us maintain lifelong social bonds through epigenetics.

Maurice Ptito was born June 11, 1946 in Casablanca, Morocco. He obtained his Ph.D. in Experimental Neuropsychology from Université de Montréal and a doctorat in Health Sciences (Doctor Medicinae) from the University of Aarhus (Denmark). He trained as post-doctoral fellow in Neurophysiology at Stanford University Medical School (California). Dr Ptito is Professor of Visual Neuroscience at the School of Optometry (Université de Montréal) He is also an Adjunct Professor of Neurology and Neurosurgery at the Montreal Neurological Institute (McGill University) and Guest Professor at the Danish Research Center for Magnetic Resonance (University of Copenhagen). He currently holds the Harland Sanders Research Chair in Vision Science.  Dr. Ptito has published four books and more than 125 scientific papers.

Awards and Prizes: Dr. Ptito has received Sir John William Dawson Medal of the Royal Society of Canada, the Henry and Karla Hensen Prize (Denmark) and a Knight of the National Order of Quebec. Honors and awards include also Canadian Psychological Association (Fellow), Royal Society of Medicine (London, Fellow), Harland Sanders Research Chair (Laureate), American Academy of Optometry Fellow, Henry and Karla Hensen prize.

Allal Boutajangout has completed his PhD in Neuropathology at Free University of Brussels, School of Medicine (ULB-Erasme Hospital) in 2005 andPostdoctoral training at New York University School of Medicine. He is a Research Associate Professor of Neurology and Neuroscience, Physiology and Psychiatry. He is also the chief of Neurodegeneration and Drug Discovery Program within Center for Cognitive Neurology at NYU.  His research focuses on a new derivative peptide of Amyloid beta for use as immunotherapy or vaccine that trains the immune system to recognize and remove amyloid-beta in the brain as well as on a novel therapy targeting one of the major hallmarks of Alzheimer’s disease, Neurofibrillary tangles. He was an integral part of the group at NYU who developed the first vaccines (active and passive immunization) targeting tau pathology in animal models of AD. More recently, he explores the possible therapeutic potential effect of the Stem Cell in AD mouse models. He is now focusing on the development of a new therapy and immunotherapy targeting Alzheimer’s disease and other related disorders such as prion, stroke and brain Injury. He has published more than 30 papers in reputed journals and serves as a reviewer for many scientific journals.

Awards and Prizes: He received prestigious award Margaret M Cahn for his outstanding research in the field of Alzheimer’s and other awards from: Alzheimer association, NIH pilot grant, Toyama Company, Revalesio Company and coinvestigator in 5 RO1 NIH grants.

Wail Benjelloun earned a Ph.D. degree from SUNY Binghamton in Psychology (Neuroscience) in 1976. He has taught since then at the Faculties of Science of Mohammed V University in Rabat at the Bachelor’s, Master’s and Doctoral levels, where he also participated in regular evaluation and academic reform projects. During his professional career, Dr. Benjelloun assumed a series of responsibilities, including Biology Department Head (1990-1994), Vice President for Academic Affairs at Al Akhawayn University in Ifrane (1994-1999), Dean of the Faculty of Science at Mohammed V University (2005-2010) and President of the same university (2010-2015). He has also been active in several Executive Boards for new universities in Morocco, as well as in several national and international commissions on higher education. He is also a member of the Moroccan-American Commission for Educational and Cultural Exchange (Fulbright Morocco). He is currently president of the Mediterranean Universities Union UNIMEDDr. Benjelloun is an active researcher, with interests centered on malnutrition and brain chemistry and behavior. He founded the first fundamental research laboratory in neuroscience in Morocco and has supervised the training of many specialists in the field. He publishes regularly in specialized international indexed journals. He was instrumental in founding the Moroccan Association for Neuroscience in 1984 and served as its president for several mandates. He also chaired the Society of Neuroscientists of Africa, and was an active member of the Executive Council of IBRO, the International Brain Research Association. He is currently President of ISP, the International Society of Pathophysiology.

Awards and Prizes: Dr. Benjelloun was decorated in 2002 as an Officer of the Order of the Throne (Morocco).​

 


 

 


The conference aims to invite researchers from around the world to meet, greet and share collaborative minds as to present the research works. The conference welcomes papers on the following (but not limited to) research topics:

- Computing Technology
- Adaptive Signal Processing
- Coding and Modulation
- Image Processing
- Artificial Intelligence
- Modulation, Coding, and Channel Analysis
- Video Compression and Streaming
- Expert Systems
- Multimedia Signal Processing
- Data Mining for Social Network Analysis
- Data Compression and Watermarking
- Text and Web Mining
- Information Security
- Network and Cyber Security
- Voice Over IP Security
- E-Commerce Security
- Security in Cloud Computing
- Information Content Security
- Wireless Communication Security
- Computer Forensics
- Security In Data Center
- Risk Management
- Practical Risk Management
- Risk Transfer Strategies
- Risk Management of IT
- Enterprise Risk Management
- Resource Risk Management
- Risk Management of Natural Disasters
- Medical Device Risk Management
- Security Risk Management

The conference uses double-blind review by at least two reviewers, which means that both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process.

Impotant Dates
Submission Deadline: August 15, 2017
Notification of Acceptance: Within 2 weeks after date of submission
Camera Ready Deadline: September 18, 2017
Registration Deadline: September 18, 2017
Conference Dates: September 28-30, 2017

MORE INFORMATION

 

Dr. Jauad EL KHARRAZ

Published in NEWS avril 06 2017 0

About

Dr. Jauad EL KHARRAZ joined the Middle East Desalination Research Center (MEDRC)[1], based at Al Hail in Muscat Governorate (Sultanate of Oman) as Director of Research on October 1st, 2015. Dr. EL KHARRAZ is in charge of delivering and developing a Research Program at that International Non-Profit Organization established to seek solutions to fresh water scarcity in the MENA region. Among other responsibilities, he will manage and develop MEDRC research activities, and maintain and grow an expert-level network of technical, academic and policy specialists on a wide range of water issues. In addition, he will provide support to the development and delivery of training programs and consultancy projects. The Middle East Desalination Research Center (MEDRC) was established to deal with two of the most pressing global and regional grand challenges; water and peace. It is a unique international organization where ten co-equal partners work together on solutions to fresh water scarcity by supporting research, training, knowledge exchange and capacity building. The MEDRC Headquarters is in Muscat in the Sultanate of Oman where it operates a state of the art research and training facility. In delivering its mission MEDRC will become a viable and transferable model for governments seeking a mechanism to address significant regional or trans-boundary environmental challenges. Dr. EL KHARRAZ has been information and projects manager at the Euro-Mediterranean Information System on know-how in the Water sector (EMWIS) Technical Unit based in Sophia Antipolis (France) for the last 11 years and half. He also worked as senior consultant for Sud-Convergences consultancy (France) in the period 2006-2008, and Expert Evaluator of the European Commission DG Research & Innovation. On the other hand, he is co-founder and General Secretary of the Arab World Association of Young Scientists (ArabWAYS), member of the Global Change Unit (University of Valencia, Spain). He is member of the Global Young Academy (GYA) that he represented in several occasions among others in the UN Disaster Risk Reduction Science & Technology group in Geneva. He was nominated in 2011 by the French Ministry of High Education & Research as representative at the Intergovernmental framework for EU Cooperation in Science & Technology (COST Action TN1301) in Brussels, where he led its Networking Working Group since end of 2011 in Vilnius (Lithuania). In 2014 he was nominated new leader for the tomorrow by Crans Montana Forum (Switzerland) and was also co-leader of water panel at the regional Think Tank WANA Forum (WANA Institute currently, Jordan). Dr. Jauad El Kharraz was one of 40 scientists worldwide selected to attend the “World Economic Forum 'Summer Davos' for New Champions” in Tianjin China in September 2012. He joined the Global Shapers Community of the World Economic by July 2014 and he became the founding curator (creator) of Nice’ hub (France) to push young talents from Nice to develop projects of development for their local community. He has published and contributed to hundreds of conferences, journals and reports in the fields of water management, agriculture, water information systems, remote sensing applications and scientific research. Moreover, he visited more than 40 countries around the world, chaired several conferences and forums sessions/panels and served as referee for many international scientific journals and international platforms. Dr. Jauad contributed to numerous projects funded by the European Commission, European Space Agency, and other regional programmes (FP5-FP7, H2020, ENPI NGO, ENPI CBC-Med, LIFE…). Dr. EL KHARRAZ has obtained his MSc and PhD in Remote Sensing from the University of Valencia (Spain). He had also a Diploma in Enterprises management & strategy from SKEMA Business School in Sophia Antipolis (France).

Source:

https://europa.eu/capacity4dev/users/jauad-el-kharraz-0


The international conference on wireless networks and mobile communications (WINCOM'17) will be held in the imperial city and administrative capital of Morocco, Rabat, on November 01-04, 2017. WINCOM'17 aims at examining the various challenges in the areas of wireless networks & mobile communications. The conference will provide a forum for exchanging ideas, discussing solutions, and sharing experiences among researchers and professionals from both academia and industry interested in wireless networks and mobile communications. WINCOM has been organized for the last four years, and that is in the form of two workshops. The first edition was held in Fez on December 25th, 2013. The second in Rabat on December 18th, 2014. In the third edition, WINCOM switches to the conference size that was organized in the imperial city of Morocco, Marrakech on October 20-23, 2015. The fourth edition was organized in the imperial city and scientific capital of Morocco, Fez, on October 26-29, 2016.

Topics of interest include, but are not limited to:

  •  Cooperative/non-cooperative communications
  •  Game theory applied to networking problems
  •  Learning theory to solve networking problems
  •  Modeling and performance evaluation
  •  Energy efficient communications and green networking
  •  Interference mitigation
  •  Physical layer design and Signal processing
  •  Channel capacity estimation, modeling and equalization
  •  Radio resource management, allocation and scheduling
  •  Congestion, load and admission control
  •  Smart antennas: MIMO, Massive MIMO and beamforming
  •  Reconfigurability, adaptivity in MAC and PHY layers
  •  Adaptive and cognitive MAC
  •  Cross-layer design involving MAC layer
  •  Routing and QoS provisioning
  •  Multihop communications: Ad hoc, WSN, DTN, VANET
  •  P2P services for multimedia
  •  Self-adaptation on the service layer
  •  Mobility Issues and continuity of services
  •  Beyond 4G and 5G communications
  •  M2M and MTC communications
  •  Cognitive radio networks
  •  Implementation, testbeds and prototypes
  •  Security issues and privacy
  •  Body area networks
  •  Internet of things (IoT)
  •  Future Internet and next-generation networking
  •  Mobile cloud computing
  •  Emerging Internet applications
  •  Context and location-awareness in pervasive systems
  •  Emerging wireless and mobile applications
  •  User interfaces, user-machine interactions
  •  User interfaces, user-machine interactions
  •  Secure network and service access
  •  Service discovery and portability
  •  Service oriented architectures
  •  Mobile health care and medical applications

WEBSITE: http://www.wincom-conf.org/ 


Science Careers has teamed up with some great organizations to bring you information about the latest career opportunities in many different fields. The profiles included in this booklet give you a sense of the types of organizations that are accepting resumes and the kinds of positions they offer. We've also included some articles with some general tips and advice on job searching.

Downloads


Déjà Vu

Déjà vu is the experience of being certain that you have experienced or seen a new situation previously – you feel as though the event has already happened or is repeating itself.

The experience is usually accompanied by a strong sense of familiarity and a sense of eeriness, strangeness, or weirdness. The “previous” experience is usually attributed to a dream, but sometimes there is a firm sense that it has truly occurred in the past.

Déjà Vécu

Déjà vécu is what most people are experiencing when they think they are experiencing deja vu.

Déjà vu is the sense of having seen something before, whereas déjà vécu is the experience of having seen an event before, but in great detail – such as recognizing smells and sounds. 

Déjà Visité

Déjà visité is a less common experience and it involves an uncanny knowledge of a new place. For example, you may know your way around a a new town or a landscape despite having never been there, and knowing that it is impossible for you to have this knowledge. 

Déjà Senti

Déjà senti is the phenomenon of having “already felt” something. This is exclusively a mental phenomenon and seldom remains in your memory afterwards.

You could think of it as the feeling of having just spoken, but realizing that you, in fact, didn’t utter a word.

Jamais Vu

Jamais vu (never seen) describes a familiar situation which is not recognized. It is often considered to be the opposite of déjà vu and it involves a sense of eeriness. The observer does not recognize the situation despite knowing rationally that they have been there before.

Chris Moulin, of Leeds University, asked 92 volunteers to write out “door” 30 times in 60 seconds. He reported that 68% of the precipitants showed symptoms of jamais vu, such as beginning to doubt that “door” was a real word. This has lead him to believe that jamais vu may be a symptom of brain fatigue.

Presque Vu

Presque vu is very similar to the “tip of the tongue” sensation – it is the strong feeling that you are about to experience an epiphany – though the epiphany seldom comes. 

L’esprit de l’Escalier

L’esprit de l’escalier (stairway wit) is the sense of thinking of a clever comeback when it is too late. 

Capgras Delusion

Capgras delusion is the phenomenon in which a person believes that a close friend or family member has been replaced by an identical looking impostor. This could be tied in to the old belief that babies were stolen and replaced by changelings in medieval folklore, as well as the modern idea of aliens taking over the bodies of people on earth to live amongst us for reasons unknown. This delusion is most common in people with schizophrenia but it can occur in other disorders.

Fregoli Delusion

Fregoli delusion is a rare brain phenomenon in which a person holds the belief that different people are, in fact, the same person in a variety of disguises. It is often associated with paranoia and the belief that the person in disguise is trying to persecute them.

It was first reported in 1927 in the case study of a 27-year-old woman who believed she was being persecuted by two actors whom she often went to see at the theatre. She believed that these people “pursued her closely, taking the form of people she knows or meets”.

Prosopagnosia

Prosopagnosia is a phenomenon in which a person is unable to recognize faces of people or objects that they should know. People experiencing this disorder are usually able to use their other senses to recognize people – such as a person’s perfume, the shape or style of their hair, the sound of their voice, or even their gait. A classic case of this disorder was presented in the 1998 book (and later Opera by Michael Nyman) called “The man who mistook his wife for a hat”.

SOURCE


Dear Researcher,

The annual Eppendorf & Science Prize for Neurobiology is an international award which honors young scientists for their outstanding contributions to neurobiological research based on methods of molecular and cell biology. The winner and finalists are selected by a committee of independent scientists, chaired by Science’s Senior Editor, Dr. Peter Stern. Researchers who are not older than 35 years are invited to apply.

The winner receives

  • Prize money of US$25,000
  • Publication in Science of an essay by the winner about his/her research
  • Full support to attend the Prize Ceremony held in conjunction with the Annual Meeting of the Society for Neuroscience in the USA
  • An invitation to visit Eppendorf in Hamburg, Germany
  • Up to three finalists are honored, too!


Application deadline: June 15, 2017

Congratulations to Gilad Evrony on winning the 2016 Eppendorf & Science Prize for his work on developing technologies to sequence and analyze the genomes of single cells from the human brain. Dr. Evrony’s research has revealed a diversity of mutations in neuronal genomes indicating that every neuron in the brain carries a unique fingerprint of somatic mutations. Such mutations can cause focal brain malformations and may have a role in other unsolved neurologic diseases. The technology also allows, for the first time, reconstruction of developmental lineage trees in the human brain to study how cells proliferate and migrate to build the brain.

It’s easy to apply!
Learn more at www.eppendorf.com/prize


On behalf of ISANH International and ISANH Middle East, it is a great pleasure to announce the organization of ISANH Middle East Antioxidants World Congress which will be held in Beirut, Lebanon, on May 3-4, 2017.

The aim of this international congress is to gather all stakeholders in antioxidants field and their impact on nutrition and health. Participants will majority come from Middle East, Africa, Europe & Asia to discuss about some strategic axes during ISANH Middle East 2017.

Beirut Antioxidants 2017 congress will be dedicated to different targets:

  • Antioxidants & Oxidative Stress in health and medicine
  • Antioxidants & functional ingredients used in food & beverage industry
  • Practical applications of antioxidants in cosmetic industry
  • Dietary Supplements in Middle East

Antioxidants and Oxidative Stress in Health & Medicine

On the first part, the scientific committee will allocate time to discuss about oxidative stress and chronic diseases. We will present the recent advances and discuss how to decrease and modulate oxidative stress related diseases such as diabetes, obesity, cancer, neurodegenerative diseases, infertility…

Clinical studies will be selected to present the subtle effects of antioxidants on health.

Antioxidants & Medical Food: Toward the personalization of medicine

During this session, the scientific committee will present the antioxidants in medical food for diabetes & obesity, cancer, ageing, neurodegenerative diseases and also specific medical food for babies and seniors.

Antioxidants & Functional ingredients in food and beverage

We cannot talk about beneficial effects of antioxidants without presenting how to formulate and use natural antioxidants.

During this session, we will answer the following questions:

  • How to use antioxidants to prevent food & beverage oxidation?
  • How to use antioxidants as antiomicrobial, natural conservators, antibacterial actor?
  • How to decrease glycation and Maillard Reaction?
  • How to decrease acrylamide formation?

A debate will be organized on the strategic theme: Natural vs synthetic antioxidants: bioavailability, toxicity and impact on gut microbiota.

A special session is dedicated to the valorization of natural sources of antioxidants, industrial byproducts as well as functional ingredients in the Middle East.

Practical Applications of Antioxidants in Cosmetic Industries

During this session we will discuss about the new trends in scientific research regarding the antioxidants in the cosmetic field. As for example:

  • Antioxidant strategies to delay skin ageing 
  • Targeting skin mitochondria: A promising strategy
  • How to increase skin antioxidant defense system?
  • Antioxidants to treat dermatologic disorders
  • Antioxidant and skin bioavailability: Recent advances and future vision

Dietary Supplements in the Middle East

Many antioxidants are used in many dietary supplements formulations to prevent diseases. The aim of session is to discuss about the recent advances, clinical studies, regulation and marketing of antioxidants in dietary supplements.

The status and regulation of dietary supplements in Europe is completely different than in Middle East. 

A round table discussion will be organized to discuss and how to harmonize the European and Middle East regulation?

https://www.isanh-me.com/welcome-2


Page 1 sur 15

Arabways Newsletter

Sign up to our newsletter

  

Recent Twitter Posts

Membership

The main criterion for election as a ARABWAYS Member is scientific excellence. Only those scientists who have made significant contributions to the advancement of science can be nominated as Members

Becoming a member is easy! Just make sure you have all of the items listed below :

  • Curriculum Vitae/Resume
  • Students and Postdocs: Proof of enrollment/status such as letter of acceptance and contact information for a department/faculty contact. 
  • Membership form